Literature DB >> 30309638

Radiotherapy for Hepatocellular Carcinoma.

Yao Yu1, Mary Feng2.   

Abstract

For patients with unresectable or medically inoperable hepatocellular carcinoma, there are many local and regional therapies available, including stereotactic body radiotherapy, radiofrequency ablation, and transcatheter embolic approaches. This article will describe these treatment options and review the current comparative literature, suggesting that stereotactic body radiotherapy provides similar or better tumor control and a favorable side effect profile.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2018        PMID： 30309638     DOI： 10.1016/j.semradonc.2018.06.005

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN： 1053-4296            Impact factor:   5.934


  8 in total

Review 1.  2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.

Authors:  Ashish Kumar; Subrat K Acharya; Shivaram P Singh; Anil Arora; Radha K Dhiman; Rakesh Aggarwal; Anil C Anand; Prashant Bhangui; Yogesh K Chawla; Siddhartha Datta Gupta; Vinod K Dixit; Ajay Duseja; Naveen Kalra; Premashish Kar; Suyash S Kulkarni; Rakesh Kumar; Manoj Kumar; Ram Madhavan; V G Mohan Prasad; Amar Mukund; Aabha Nagral; Dipanjan Panda; Shashi B Paul; Padaki N Rao; Mohamed Rela; Manoj K Sahu; Vivek A Saraswat; Samir R Shah; Praveen Sharma; Sunil Taneja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2019-09-23

2.  Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.

Authors:  Liming Wang; Weihu Wang; Weiqi Rong; Zhuo Li; Fan Wu; Yunhe Liu; Yiling Zheng; Kai Zhang; Tana Siqin; Mei Liu; Bo Chen; Jianxiong Wu
Journal:  BMC Cancer       Date:  2020-07-01       Impact factor: 4.430

3.  Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway.

Authors:  Wei Chen; Tao Wei; Yinghua Chen; Lan Yang; Xiaomin Wu
Journal:  Onco Targets Ther       Date:  2020-12-14       Impact factor: 4.147

4.  Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis.

Authors:  Chieh-Min Liu; Bing-Shen Huang; Yi-Hao Yen; Yu-Ming Wang; Eng-Yen Huang; Hsuan-Chih Hsu; Tzu-Ting Huang; Yao-Hsu Yang; Jen-Yu Cheng
Journal:  J Hepatocell Carcinoma       Date:  2021-08-18

5.  LncRNA LINC01134 Contributes to Radioresistance in Hepatocellular Carcinoma by Regulating DNA Damage Response via MAPK Signaling Pathway.

Authors:  Zhiyi Wang; Xinxing Wang; Zhonghou Rong; Longfei Dai; Chengkun Qin; Shikang Wang; Wenmao Geng
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

Review 6.  An emerging role of radiation‑induced exosomes in hepatocellular carcinoma progression and radioresistance (Review).

Authors:  Qing Fan; Yue Yu; Yueling Zhou; Sheng Zhang; Chunli Wu
Journal:  Int J Oncol       Date:  2022-03-10       Impact factor: 5.650

7.  Upregulation of hypoxia-inducible factor 1α mRNA expression was associated with poor prognosis in patients with hepatocellular carcinoma.

Authors:  Wei Cheng; Ziwei Cheng; Zongguo Yang; Dongwei Xing; Minguang Zhang
Journal:  Onco Targets Ther       Date:  2019-08-09       Impact factor: 4.147

8.  Possible involvement of HSP70 in pancreatic cancer cell proliferation after heat exposure and impact on RFA postoperative patient prognosis.

Authors:  Hui-Bin Song
Journal:  Biochem Biophys Rep       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.